SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-140533
Filing Date
2024-05-16
Accepted
2024-05-16 16:06:35
Documents
19
Period of Report
2024-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d813909d8k.htm   iXBRL 8-K 36520
2 EX-1.1 d813909dex11.htm EX-1.1 279882
3 EX-4.1 d813909dex41.htm EX-4.1 70652
4 EX-5.1 d813909dex51.htm EX-5.1 11587
5 EX-99.1 d813909dex991.htm EX-99.1 9736
9 GRAPHIC g813909g0513025904999.jpg GRAPHIC 2746
10 GRAPHIC g813909g0516084016188.jpg GRAPHIC 4603
  Complete submission text file 0001193125-24-140533.txt   657190

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA glue-20240515.xsd EX-101.SCH 2850
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE glue-20240515_lab.xml EX-101.LAB 18737
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glue-20240515_pre.xml EX-101.PRE 11707
22 EXTRACTED XBRL INSTANCE DOCUMENT d813909d8k_htm.xml XML 3773
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40522 | Film No.: 24955534
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)